The progression of IBD is known to be promoted by upregulated genetic regulatory networks of chemokines, cytokines, other pro-inflammatory factors (S100A8/A9, CSF3, etc.), extracellular matrix breakdown enzymes, and coagulation (2, 5–13). Here, CSF3 is linked to inflammatory bowel disease.